The Division of Cancer Treatment and Diagnosis (DCTD) is breaking new ground in cancer care with innovative diagnostics and treatments. Through programs like the Cancer Therapy Evaluation Program, the DCTD assesses new anticancer agents and radiation treatments, while the Cancer Imaging Program focuses on the role of imaging in diagnosis and monitoring. Celebrated initiatives like the NCI-60 ComboMATCH initiative and breakthroughs like Blinatumomab are changing our understanding of tumors and shaping the future of cancer treatment. The DCTD fosters collaborations with academia and industry, spurring novel strategies in cancer care, while providing funding opportunities and resources to aid in forming new therapies. With success stories that range from changing pre-operative strategies in rectal cancer to battling rare melanomas, the DCTD's impact on cancer care is transformative. By consistently expanding cancer research boundaries, encouraging partnerships and implementing research into clinical practice, the DCTD is redesigning cancer care.
Full article here: https://medium.com/@lawsuithelpdesk/revolutionizing-cancer-care-a-deep-dive-into-the-innovative-diagnostics-treatments-and-1a60781f13b3